NCT01023646

Brief Summary

The purpose of this study is to determine the variability in glycemic index determinations for individual foods and food combinations. The study will also evaluate the changes in insulin and free fatty acid levels, plasma lipid and lipoprotein profiles, C-reactive protein-a marker of inflammation and glycosylated hemoglobin- a marker of glucose metabolism during a five-hour period after eating the food or foods. Additionally, supplementary data on variation in oral sensation, habitual food intake, food preferences and genes mediating sensory perception and dietary behaviors (supported by a grant from the Tufts Ross Aging Initiative) will be related to the outcomes on the present study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable diabetes

Timeline
Completed

Started Dec 2007

Longer than P75 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2009

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 25, 2017

Status Verified

April 1, 2017

Enrollment Period

7.9 years

First QC Date

November 30, 2009

Last Update Submit

April 24, 2017

Conditions

Keywords

Glycemic IndexGlycemic LoadGlucoseInsulinLipoproteinsFree fatty acids

Outcome Measures

Primary Outcomes (1)

  • Glucose, Insulin, Free Fatty Acids.

    5 hours

Secondary Outcomes (1)

  • Fasting and non-fasting plasma lipids and lipoproteins, C reactive protein (CRP), HbAIc.

    5 hours

Study Arms (4)

carbohydrate load

OTHER

Food challenge - Carbohydrate load

Other: Carbohydrate load

Carbohydrate + Protein

OTHER

Food challenge - carbohydrate + protein

Other: Carbohydrate + Protein

Carbohydrate + Fat

OTHER

Food challenge - carbohydrate + fat

Other: Carbohydrate + Fat

Fiber

OTHER

Food challenge - carbohydrate + fiber

Other: Fiber

Interventions

Light Tuna Packed in water.

Carbohydrate + Protein

Butter

Carbohydrate + Fat
FiberOTHER

Unrefined Carbohydrate

Fiber

Carbohydrate

carbohydrate load

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For Phase 1 (Study 1) a total of seventy five volunteers will be included in the study. This study will be conducted in adult men and women (18-85 y) free of known chronic disease with BMI 18 to 35 kg/m2.
  • For Phase 2 (Studies 2, 3, 4, and 5) a total of 80 volunteers will be included, 20 volunteers per study. Phase 2 studies will be conducted in adult men and women (50 - 85 y) free of known chronic disease and with a BMI of 25 to 35 kg/m2.
  • For Phase 3 (Study 6) a total of 20 volunteers will be included in the study. Phase 3 study will be conducted in adult men and women (50-85 y) free of known chronic disease and with a BMI of 25 to 35 kg/m2.

You may not qualify if:

  • BMI ≥ 35 kg/m2 for Phase I, and BMI ≤ 25 to ≥ 35 kg/m2 for Phase II and III
  • Renal disease, as defined by a history of chronic kidney disease or by glomerular filtration rate of \< 60 ml.min/1.73 m2 calculated from screening blood tests.
  • Liver disease, as defined by a history of chronic hepatitis B or C, cholestatic or cirrhotic liver disease, nonalcoholic fatty liver disease, elevations of serum glutamate pyruvate transaminase (SGPT) or serum glutamate oxaloacetate transaminase (SGOT) greater than 1.5 times the upper limit of normal at screening, bilirubin greater than 2 mg/dL (in the absence of benign causes of elevated bilirubin such as Gilbert's syndrome) at screening, or albumin below the lower limit of normal.
  • Untreated hypertension, defined as systolic blood pressure (SBP) \> 140 mm and diastolic blood pressure (DBP) \> 90 mm.
  • Irritable bowel syndrome.
  • Malabsorptive disorder and inflammatory bowel disease.
  • Disorders of esophageal and gastrointestinal motility, and previous esophageal or gastric resection.
  • History of chronic pancreatitis, or history of acute pancreatitis within the last year.
  • Hypothyroidism or hyperthyroidism, as defined as screening thyroid-stimulating hormone (TSH) outside of normal ranges.
  • Anemia, as defined by screening hematocrit of 34% for women and 38% for men.
  • Smoking within the past 6 months.
  • Diabetes.
  • Fasting glucose ≥ 125 mg/dL.
  • Pregnancy.
  • Breastfeeding.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University

Boston, Massachusetts, 02111, United States

Location

Related Publications (16)

  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486. No abstract available.

    PMID: 11368702BACKGROUND
  • Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981 Mar;34(3):362-6. doi: 10.1093/ajcn/34.3.362.

    PMID: 6259925BACKGROUND
  • Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997 Feb 12;277(6):472-7. doi: 10.1001/jama.1997.03540300040031.

    PMID: 9020271BACKGROUND
  • Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997 Apr;20(4):545-50. doi: 10.2337/diacare.20.4.545.

    PMID: 9096978BACKGROUND
  • Amano Y, Kawakubo K, Lee JS, Tang AC, Sugiyama M, Mori K. Correlation between dietary glycemic index and cardiovascular disease risk factors among Japanese women. Eur J Clin Nutr. 2004 Nov;58(11):1472-8. doi: 10.1038/sj.ejcn.1601992.

    PMID: 15127092BACKGROUND
  • Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr. 2004 Aug;80(2):348-56. doi: 10.1093/ajcn/80.2.348.

    PMID: 15277155BACKGROUND
  • Wolever TM, Csima A, Jenkins DJ, Wong GS, Josse RG. The glycemic index: variation between subjects and predictive difference. J Am Coll Nutr. 1989 Jun;8(3):235-47. doi: 10.1080/07315724.1989.10720298.

    PMID: 2760355BACKGROUND
  • Wolever TM, Jenkins DJ, Josse RG, Wong GS, Lee R. The glycemic index: similarity of values derived in insulin-dependent and non-insulin-dependent diabetic patients. J Am Coll Nutr. 1987 Aug;6(4):295-305. doi: 10.1080/07315724.1987.10720191.

    PMID: 3611527BACKGROUND
  • Jenkins DJ, Wolever TM, Wong GS, Kenshole A, Josse RG, Thompson LU, Lam KY. Glycemic responses to foods: possible differences between insulin-dependent and noninsulin-dependent diabetics. Am J Clin Nutr. 1984 Nov;40(5):971-81. doi: 10.1093/ajcn/40.5.971.

    PMID: 6496392BACKGROUND
  • Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002 Jul;76(1):5-56. doi: 10.1093/ajcn/76.1.5.

    PMID: 12081815BACKGROUND
  • Wolever TM, Vorster HH, Bjorck I, Brand-Miller J, Brighenti F, Mann JI, Ramdath DD, Granfeldt Y, Holt S, Perry TL, Venter C, Xiaomei Wu. Determination of the glycaemic index of foods: interlaboratory study. Eur J Clin Nutr. 2003 Mar;57(3):475-82. doi: 10.1038/sj.ejcn.1601551.

    PMID: 12627186BACKGROUND
  • Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr. 1986 Jan;43(1):167-72. doi: 10.1093/ajcn/43.1.167.

    PMID: 3942088BACKGROUND
  • Vega-Lopez S, Ausman LM, Griffith JL, Lichtenstein AH. Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care. 2007 Jun;30(6):1412-7. doi: 10.2337/dc06-1598. Epub 2007 Mar 23.

    PMID: 17384339BACKGROUND
  • Meng H, Matthan NR, Ausman LM, Lichtenstein AH. Effect of prior meal macronutrient composition on postprandial glycemic responses and glycemic index and glycemic load value determinations. Am J Clin Nutr. 2017 Nov;106(5):1246-1256. doi: 10.3945/ajcn.117.162727. Epub 2017 Sep 13.

  • Meng H, Matthan NR, Ausman LM, Lichtenstein AH. Effect of macronutrients and fiber on postprandial glycemic responses and meal glycemic index and glycemic load value determinations. Am J Clin Nutr. 2017 Apr;105(4):842-853. doi: 10.3945/ajcn.116.144162. Epub 2017 Feb 15.

  • Matthan NR, Ausman LM, Meng H, Tighiouart H, Lichtenstein AH. Estimating the reliability of glycemic index values and potential sources of methodological and biological variability. Am J Clin Nutr. 2016 Oct;104(4):1004-1013. doi: 10.3945/ajcn.116.137208. Epub 2016 Sep 7.

MeSH Terms

Conditions

Diabetes MellitusObesityMetabolic SyndromeCardiovascular DiseasesInsulin Resistance

Interventions

CarbohydratesProteinsCD36 AntigensDietary Fiber

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinism

Intervention Hierarchy (Ancestors)

Amino Acids, Peptides, and ProteinsPlatelet Membrane GlycoproteinsMembrane GlycoproteinsGlycoproteinsGlycoconjugatesFatty Acid Transport ProteinsMembrane Transport ProteinsCarrier ProteinsMembrane ProteinsReceptors, Cell SurfaceReceptors, ImmunologicScavenger Receptors, Class BReceptors, ScavengerReceptors, LDLReceptors, LipoproteinDietary CarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Alice H Lichtenstein, D.Sc.

    JM USDA Human Nutrition Research Center on Aging at Tufts University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2009

First Posted

December 2, 2009

Study Start

December 1, 2007

Primary Completion

November 1, 2015

Study Completion

December 1, 2016

Last Updated

April 25, 2017

Record last verified: 2017-04

Locations